Showing results (441-450 of 451) with videos related to

Sort By:
Pageof 46
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
The New England Journal of Medicine|April 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
Communications Biology|June 10, 2023
Decadal stability in coral cover could mask hidden changes on reefs in the East Asian SeasY K S Chan, Y A Affendi, P O Ang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or OlderAaron T Chin, Hans D Ochs, Roger Kobayashi, et al.
Nature Medicine|January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous diseaseDonald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
Pageof 46